Ronald Blue Trust, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,485 shares of AMPH stock, worth $66,914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,485
Previous 1,604
7.42%
Holding current value
$66,914
Previous $64,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
283Shares Held
35.1MCall Options Held
57KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$268 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$122 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$96.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$87.7 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$72.8 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.21B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...